A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 5, 2010, Pages 1059-1065

  Beissner, Marcus ^a   Awua Boateng, Nana Yaa ^b   Thompson, William ^c   Nienhuis, Willemien A ^d   Klutse, Erasmus ^e   Agbenorku, Pius ^f   Nitschke, Joerg ^a   Herbinger, Karl Heinz ^a   Siegmund, Vera ^a   Fleischmann, Erna ^a   Adjei, Ohene ^b   Fleischer, Bernhard ^g   Van Der Werf, Tjip S ^d   Loscher, Thomas ^a   Bretzel, Gisela ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^c Agogo Presbyterian Hospital   (Ghana)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Dunkwa Governmental Hospital   (Ghana)

^f KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^g BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BURULI ULCER; CLINICAL ASSESSMENT; CLINICAL FEATURE; CODON; DNA SEQUENCE; EXTRACT; GENOME; GENOTYPE; GHANA; HUMAN; MAJOR CLINICAL STUDY; MONITORING; MYCOBACTERIOSIS; MYCOBACTERIUM ULCERANS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PREVALENCE; SEQUENCE ANALYSIS; WILD TYPE; ANTIBIOTIC RESISTANCE; CLASSIFICATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; PHYSIOLOGY;

MYCOBACTERIUM ULCERANS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BURULI ULCER; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; GHANA; HUMANS; MUTATION; MYCOBACTERIUM ULCERANS;

EID: 79952063164     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0263     Document Type: Article

References (37)

1. World Health Organization, 2008. Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 17: 145-154.
2. World Health Organization, 2004. Provisional Guidance on the Role of Specific Antibiotics in the Management of Mycobacterium ulcerans Disease (Buruli Ulcer). Geneva, Switzerland: World Health Organization.
3. Siegmund V, Adjei O, Nitschke J, Thompson W, Klutse E, Herbinger KH, Thompson R, van Vloten F, Racz P, Fleischer B, Loescher T, Bretzel G, 2007. Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease. Clin Infect Dis 45: 68-75. (Pubitemid 46984618)
4. Schunk M, Thompson W, Klutse E, Nitschke J, Opare-Asamoah K, Thompson R, Fleischmann E, Siegmund V, Herbinger KH, Adjei O, Fleischer B, Loscher T, Bretzel G, 2009. Outcome of patients with Buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana. Am J Trop Med Hyg 81: 75-81.
5. Herbinger KH, Adjei O, Awua-Boateng NY, Nienhuis WA, Kunaa L, Siegmund V, Nitschke J, Thompson W, Klutse E, Agbenorku P, Schipf A, Reu S, Racz P, Fleischer B, Beissner M, Fleischmann E, Helfrich K, van der Werf TS, Loscher T, Bretzel G, 2009. Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 48: 1055-1064.
6. World Health Organization, 2008. Anti-Tuberculosis Drug Resistance in the World. Report No. 4. Geneva, Switzerland: World Health Organization.
7. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, Simpson J, Gie RP, Enarson DA, Beyers N, van Helden PD, Victor TC, 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39: 636-641. (Pubitemid 32150832)
8. Telenti A, Honore N, Bernasconi C, March J, Ortega A, Heym B, Takiff HE, Cole ST, 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35: 719-723. (Pubitemid 27083868)
9. World Health Organization, 2007. Rifampicin Resistance in Leprosy. Report of an Informal Consultation. Geneva, Switzerland: World Health Organization.
10. Matsuoka M, Budiawan T, Aye KS, Kyaw K, Tan EV, Cruz ED, Gelber R, Saunderson P, Balagon V, Pannikar V, 2007. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr Rev 78: 343-352. (Pubitemid 351171803)
11. World Health Organization, 2009. Guidelines for Global Surveillance of Drug Resistance in Leprosy. Geneva, Switzerland: World Health Organization.
12. Morlock GP, Plikaytis BB, Crawford JT, 2000. Characterization of spontaneous in vitro -selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother 44: 3298-3301. (Pubitemid 33009486)
13. Sapkota BR, Ranjit C, Neupane KD, Macdonald M, 2008. Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae. J Med Microbiol 57: 179-184. (Pubitemid 351231401)
14. Das R, Gupta P, Singh P, Chauhan DS, Katoch K, Katoch VM, 2009. Association of mutations in rpsL gene with high degree of streptomycin resistance in clinical isolates of Mycobacterium tuberculosis in India. Indian J Med Res 129: 108-110.
15. Mieskes KT, Rusch-Gerdes S, Truffot-Pernot C, Feldmann K, Tortoli E, Casal M, Loscher T, Rinder H, 2000. Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis. Am J Trop Med Hyg 63: 56-60. (Pubitemid 32423095)
16. Marsollier L, Honore N, Legras P, Manceau AL, Kouakou H, Carbonnelle B, Cole ST, 2003. Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. Antimicrob Agents Chemother 47: 1228-1232. (Pubitemid 36368579)
17. Nienhuis WA, Stienstra Y, Thompson WA, Awuah PC, Abass KM, Tuah W, Awua-Boateng NY, Ampadu EO, Siegmund V, Schouten JP, Adjei O, Bretzel G, van der Werf TS, 2010. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomized controlled trial. Lancet 375: 664-672.
18. Stinear T, Ross BC, Davies JK, Marino L, Robins-Browne RM, Oppedisano F, Sievers A, Johnson PD, 1999. Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol 37: 1018-1023. (Pubitemid 29140608)
19. Siegmund V, Adjei O, Racz P, Berberich C, Klutse E, van Vloten F, Kruppa T, Fleischer B, Bretzel G, 2005. Dry reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans -associated disease in areas in the tropics where M. ulcerans is endemic. J Clin Microbiol 43: 271-276. (Pubitemid 40096311)
20. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson R, Fleischmann E, Fleischer B, Adjei O, 2006. External quality assurance for the laboratory diagnosis of Buruli ulcer disease in Ghana. Trop Med Int Health 11: 1688-1693. (Pubitemid 44624371)
21. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, Klutse E, Crofts K, Massavon W, Etuaful S, Thompson R, Asamoah-Opare K, Racz P, Vloten F, van Berberich C, Kruppa T, Ampadu E, Fleischer B, Adjei O, 2007. A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health 12: 89-96. (Pubitemid 44973858)
22. Kim BJ, Lee SH, Lyu MA, Kim SJ, Bai GH, Chae GT, Kim EC, Cha CY, Kook YH, 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 37: 1714-1720.
23. Talaat AM, Reimschuessel R, Trucksis M, 1997. Identification of mycobacteria infecting fish to the species level using polymerase chain reaction and restriction enzyme analysis. Vet Microbiol 58: 229-237. (Pubitemid 28026786)
24. Turenne CY, Tschetter L, Wolfe J, Kabani A, 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 39: 3637-3648. (Pubitemid 32954514)
25. Kim H, Kim SH, Shim TS, Kim MN, Bai GH, Park YG, Lee SH, Cha CY, Kook YH, Kim BJ, 2005. PCR restriction fragment length polymorphism analysis (PRA)-algorithm targeting 644 bp Heat Shock Protein 65 (hsp65) gene for differentiation of Mycobacterium spp. J Microbiol Methods 62: 199-209. (Pubitemid 40991439)
26. Roth A, Reischl U, Streubel A, Naumann L, Kroppenstedt RM, Habicht M, Fischer M, Mauch H, 2000. Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. J Clin Microbiol 38: 1094-1104.
27. World Health Organization, 2007. Summary Report of the WHO Annual Meeting on Buruli Ulcer. Geneva, Switzerland: World Health Organization.
28. Eddyani M, Ofori-Adjei D, Teugels G, De Weirdt D, Boakye D, Meyers WM, Portaels F, 2004. Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol 70: 5679-5681. (Pubitemid 39279647)
29. Johnson PD, Azuolas J, Lavender CJ, Wishart E, Stinear TP, Hayman JA, Brown L, Jenkin GA, Fyfe JA, 2007. Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis 13: 1653-1660. (Pubitemid 350126191)
30. van der Werf TS, Stienstra Y, Johnson RC, Phillips R, Adjei O, Fleischer B, Wansbrough-Jones MH, Johnson PD, Portaels F, van der Graaf WT, Asiedu K, 2005. Mycobacterium ulcerans disease. Bull World Health Organ 83: 785-791. (Pubitemid 41474698)
31. Debacker M, Zinsou C, Aguiar J, Meyers WM, Portaels F, 2003. First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite. Clin Infect Dis 36: e67-e68.
32. Maranes Antonanzas I, Lopez Gallardo Y, Garcia Pardo A, Abella Vazquez ML, 2006. Transmission of Buruli ulcer from person to person. Rev Clin Esp 206: 256-257.
33. Asiedu K, Wansbrough-Jones M, 2007. Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies. Med J Aust 186: 55-56. (Pubitemid 46178814)
34. Eddyani M, Debacker M, Martin A, Aguiar J, Johnson CR, Uwizeye C, Fissette K, Portaels F, 2008. Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol 46: 69-72.
35. Pierre-Audigier C, 1994. Recent biological techniques for the diagnosis of mycobacterial infections. Presse Med 23: 665-670. (Pubitemid 24217059)
36. Hosek J, Svastova P, Moravkova M, Pavlik I, Bartos M, 2006. Methods of mycobacterial DNA isolation from different biological material: a review. Vet Med (Praha) 51: 180-192. (Pubitemid 43764154)
37. Marsollier L, Robert R, Aubry J, Saint Andre JP, Kouakou H, Legras P, Manceau AL, Mahaza C, Carbonnelle B, 2002. Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol 68: 4623-4628.